Advertisement
Loading...

Ascendis Pharma A/S

ASND•NASDAQ
Healthcare
Biotechnology
$245.49
$1.91(0.78%)
U.S. Market is Open • 09:41

Ascendis Pharma A/S (ASND) Stock Overview

Explore Ascendis Pharma A/S’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap15.2B
P/E Ratio25.44
EPS (TTM)$8.92
ROE-56.42%
Fundamental Analysis

AI Price Forecasts

1 Month$223.83
3 Months$259.48
1 Year Target$187.08

ASND Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ascendis Pharma A/S (ASND) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.63, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $187.08.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 25.44 and a market capitalization of 15.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.78%
5-Day Change
-0.26%
1-Month Change
-1.74%
3-Month Change
13.48%
6-Month Change
20.10%
Year-to-Date (YTD) Change
15.12%
1-Year Change
56.16%
3-Year Change
154.16%
5-Year Change
85.72%
All-Time (Max) Change
1203.72%

Contact Information

https://ascendispharma.com
45 70 22 22 44
Tuborg Boulevard 12, Hellerup, NaN, 2900

Company Facts

1,017 Employees
IPO DateJan 28, 2015
CountryDK
Actively Trading

Frequently Asked Questions